Research Paper Volume 15, Issue 22 pp 13265—13286
Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patients
Figure 3. KLRB1-associated prognostic nomograms in BRCA patients. (A) OS; (B) PFI; (C) DSS. Abbreviations: BRCA: breast invasive carcinoma; OS: overall survival; PFI: progress free interval; DSS: disease specific survival.